BlackRock Japan’s West Pharmaceutical WST Stock Holding History

BlackRock Japan’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,247	Closed	-$93K	–	1377
2016 Q3	$93K	Sell	1,247 -740	-37%	-$58.7K	﹤0.01%	891
2016 Q2	$151K	Buy	+1,987	New	+$145K	﹤0.01%	846
2014 Q2	–	Sell	-7,015	Closed	-$309K	–	1409
2014 Q1	$309K	Buy	7,015 +5,818	+486%	+$274K	﹤0.01%	850
2013 Q4	$59K	Buy	+1,197	New	+$56K	﹤0.01%	1106

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock Japan's WST Position: Q4 2016 in Review

BlackRock Japan sold out of West Pharmaceutical (WST) in Q4 2016, closing a stake of 1,247 shares — an estimated $93K sold.

BlackRock Japan first reported a position in WST in Q4 2013 and held it in 4 quarters. The position peaked at $309K in Q1 2014. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

BlackRock Japan reported no remaining West Pharmaceutical position as of Q4 2016 after selling out during the quarter.
BlackRock Japan sold 1,247 West Pharmaceutical shares in Q4 2016, an estimated $93K.
BlackRock Japan first reported a position in West Pharmaceutical in Q4 2013 and held it in 4 quarters.
BlackRock Japan's West Pharmaceutical position peaked at $309K in Q1 2014.
288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.